Pharmaceutical Business Review
Return to: PBR Home | Companies

Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Inc
Suite 400
395 Oyster Point Boulevard
South San Francisco
United States of America
Phone: 1 650 2663500
Fax: 16-50-2663501
www.sunesis.com

No. employees: 34
Turnover: 00.67 (US$m)
Financial year end: December

Company Overview

Top Competitors


Key Employees

Dayton Misfeldt

Interim Chief Executive Officer, Director, Executive Board

James W. Young, Ph.D.

Chairman, Executive Board

David C. Stump, M.D.

Director, Non Executive Board

Steve R. Carchedi

Director, Non Executive Board

Homer L. Pearce, Ph.D.

Director, Non Executive Board

Steven B. Ketchum, Ph.D.

Director, Non Executive Board

H. Ward Wolff

Director, Non Executive Board

Parvinder S. Hyare

Vice President - Global Oncology Operations, Senior Management

Deborah A. Thomas, Ph.D.

Senior Vice President - Regulatory Affairs, Quality Assurance and Pharmacovigilance, Senior Management

Judith A. Fox, Ph.D.

Chief Scientific Officer, Senior Management

Jennifer A. Smith, Ph.D.

Vice President - Biometrics, Senior Management

William P. Quinn

Chief Financial Officer, Senior Vice President - Finance and Corporate Development, Senior Management

Locations/Subsidiaries


Suite 400,
395 Oyster Point Boulevard,
South San Francisco,
California,
United States of America
Phone: 1 650 2663500
Fax: 1 650 2663501

Sunesis Pharmaceuticals (Bermuda) Ltd

Bermuda

Sunesis Pharmaceuticals International LP

Bermuda

Sunesis Europe Ltd

19 Leyden Street ,
London,
Greater London,
United Kingdom

Products/Services


Products:

  • Vvosaroxin
  • TAK-580
  • SNS-062
  • SNS-510